Routine nebulized ipratropium and albuterol together are better than either alone in COPD

Chest

Volumn 112, Issue 6, 1997, Pages 1514-1521

  Auerbach, D ^a   Hill, C ^a   Baughman, R ^a   Boyars, M ^a   Braun, S ^a   Buist, A S ^a   Campbell, S C ^a   Chick, T ^a   Cohen, B ^a   Colice, G ^a   Dunn, L ^a   Friedman, M ^a   Gilman, M ^a   Gorin, A ^a   Gross, N ^a   Jenkinson, S ^a   Levine, B ^a   Libert, R ^a   Liu, J ^a   Mestas, G ^a   O'Connor, R ^a   Ramsdell, J ^a   Rowlands, J ^a   Serby, C W ^a   Warmer, A ^a   Weiss, S ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; SALBUTAMOL SULFATE; TERBUTALINE;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; NEBULIZER; NERVOUSNESS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME; XEROSTOMIA;

EID: 3042804527     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.6.1514     Document Type: Article

References (3)

1. Casali L, Grassi C, Rampulla C, et al. Clinical pharmacology of a combination of bronchodilators. Int J Clin Pharmacol Biopharm 1979; 7:277-80
2. Lees AW, Allan GW, Smith J. Nebulised ipratropium bromide and salbutamol in chronic bronchitis. Br J Clin Pract 1980; 3:340-42
3. Leitch AG, Hopkin JM, Ellis DA, et al. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax 1978; 33:711-13